# The TPx protein of Taenia solium metacestode regulates Treg and Th17 cell differentiation via the TGF-β/Smad signaling pathway

**Authors:** Xiaoqing Sun, Qianqian Mu, Biying Zhou

PMC · DOI: 10.3389/fimmu.2026.1612077 · Frontiers in Immunology · 2026-02-06

## TL;DR

This study shows how a protein from a tapeworm affects immune cells, causing an imbalance that could help explain how a parasitic infection causes disease.

## Contribution

The study identifies the TGF-β/Smad pathway as a novel mechanism by which TPx protein regulates Treg and Th17 cell differentiation.

## Key findings

- TPx protein induces a Treg/Th17 cell imbalance through TGF-β/Smad signaling.
- Foxp3 expression increases while RORC(γt) decreases in TPx-treated cells.
- TGF-β1, TGF-βR2, and p-Smad3 are upregulated following TPx exposure.

## Abstract

The immunopathogenesis of cysticercosis remains elusive. This study investigates the effects of Taenia solium metacestode-derived thioredoxin peroxidase (TPx) protein on regulatory T (Treg) cells and T helper 17 (Th17) cell differentiation, as well as its correlation with signaling pathways in human Jurkat T lymphocytes exposed to TPx for varying durations, to provide a scientific basis for further studying the immune pathogenesis and clinical treatment of cysticercosis.

TPx protein from the excretory-secretory antigens of T. solium metacestode was used to stimulate Jurkat cells at various timepoints. Flow cytometry was employed to detect the expression of CD4+CD25+CD127- Treg cells and CD4+IL-17A+ Th17 cells. Transcriptomic analysis was performed to identify the signaling pathways related to the differentiation of Jurkat cells under the influence of the TPx protein at different time points. The expression levels of TGF-β1, TGF-βR2, Smad4, Foxp3, RORC(γt), and phosphorylated Smad3 proteins were measured in TPx-treated cells and control cells at different time points.

A Treg/Th17 cell imbalance was detected in Jurkat cells following exposure to TPx, characterized by a Treg-mediated predominant immunosuppressive response. Gene Set Enrichment Analysis identified significant enrichment of the TGF-β signaling pathway and Th17 cell differentiation pathway in TPx-treated cells. TPx significantly upregulated TGF-β1, TGF-βR2, and p-Smad3 expression in cells (P < 0.05). Concurrently, the expression of Foxp3, a key transcriptional regulator of Treg cell differentiation, was markedly increased (P < 0.05). In contrast, the expression of RORC(γt), a transcription factor critical for Th17 cell differentiation, showed significant reduction after 72 h of TPx induction (P < 0.05).

The TGF-β/Smad signaling pathway is a crucial molecular mechanism involved in the imbalance of Treg/Th17 cells induced by the TPx protein of T. solium metacestode.

The TPx protein of Cysticercus cellulosae regulates the expression levels of Foxp3 and RORC (γt) by activating the TGF-β/Smad signaling pathway. Early (24 h) differentiation of Treg cells is slightly inhibited, while differentiation of Treg cells is promoted and differentiation of Th17 cells is inhibited in the mid to late stages (48 h, 72 h). This leads to an imbalance of host Treg/Th17 cells, resulting in an immune response predominantly characterized by Treg cells. This study primarily investigates the effects of the TPx protein on the differentiation of Treg and Th17 cells and its correlation with the TGF-β/Smad signaling pathway, providing important scientific evidence for further exploration of the immunopathogenesis of Cysticercosis.Illustration of TGF-beta signaling pathway at 0, 24, 48, and 72 hours showing Smad2/3 and Smad4 interaction. Graph depicts expression changes in Foxp3 and ROR-gamma-t, influencing Treg and Th17 cells. Results indicate shifts in immune tolerance and inflammation through TGF-beta, IL-10, and IL-17 expression levels.

The TPx protein of Cysticercus cellulosae regulates the expression levels of Foxp3 and RORC (γt) by activating the TGF-β/Smad signaling pathway. Early (24 h) differentiation of Treg cells is slightly inhibited, while differentiation of Treg cells is promoted and differentiation of Th17 cells is inhibited in the mid to late stages (48 h, 72 h). This leads to an imbalance of host Treg/Th17 cells, resulting in an immune response predominantly characterized by Treg cells. This study primarily investigates the effects of the TPx protein on the differentiation of Treg and Th17 cells and its correlation with the TGF-β/Smad signaling pathway, providing important scientific evidence for further exploration of the immunopathogenesis of Cysticercosis.

## Linked entities

- **Genes:** FOXP3 (forkhead box P3) [NCBI Gene 50943], RORC (RAR related orphan receptor C) [NCBI Gene 6097], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], TGFBR2 (transforming growth factor beta receptor 2) [NCBI Gene 7048], SMAD4 (SMAD family member 4) [NCBI Gene 4089]
- **Proteins:** TPO (thyroid peroxidase), TGFB1 (transforming growth factor beta 1), TGFBR2 (transforming growth factor beta receptor 2), SMAD4 (SMAD family member 4), FOXP3 (forkhead box P3)
- **Diseases:** cysticercosis (MONDO:0015484)
- **Species:** Taenia solium (taxon 6204)

## Full-text entities

- **Genes:** FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, HAVCR1 (hepatitis A virus cellular receptor 1) [NCBI Gene 26762] {aka CD365, HAVCR, HAVCR-1, KIM-1, KIM1, TIM}, TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, IL2RA (interleukin 2 receptor subunit alpha) [NCBI Gene 3559] {aka CD25, IDDM10, IL2R, IMD41, TCGFR, p55}, SMAD4 (SMAD family member 4) [NCBI Gene 4089] {aka DPC4, JIP, MADH4, MYHRS}, MAPK7 (mitogen-activated protein kinase 7) [NCBI Gene 5598] {aka BMK1, ERK4, ERK5, PRKM7}, RUNX1 (RUNX family transcription factor 1) [NCBI Gene 861] {aka AML1, AML1-EVI-1, AMLCR1, CBF2alpha, CBFA2, EVI-1}, RPGRIP1 (RPGR interacting protein 1) [NCBI Gene 57096] {aka CORD13, LCA6, RGI1, RGRIP, RPGRIP, RPGRIP1d}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, TGFBR2 (transforming growth factor beta receptor 2) [NCBI Gene 7048] {aka AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, RORC (RAR related orphan receptor C) [NCBI Gene 6097] {aka IMD42, NR1F3, RORG, RZR-GAMMA, RZRG, TOR}, AMY1B (amylase alpha 1B) [NCBI Gene 277] {aka AMY1}, SDC2 (syndecan 2) [NCBI Gene 6383] {aka CD362, HSPG, HSPG1, SYND2}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, ZNF280A (zinc finger protein 280A) [NCBI Gene 129025] {aka 3'OY11.1, SUHW1, ZNF280, ZNF636}, WNT5A (Wnt family member 5A) [NCBI Gene 7474] {aka hWNT5A}, IL7R (interleukin 7 receptor) [NCBI Gene 3575] {aka CD127, CDW127, IL-7R-alpha, IL-7Ralpha, IL7RA, IL7Ralpha}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, CTSE (cathepsin E) [NCBI Gene 1510] {aka CATE}, SMAD3 (SMAD family member 3) [NCBI Gene 4088] {aka HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3}, CLDN11 (claudin 11) [NCBI Gene 5010] {aka HLD22, OSP, OTM}, TGFBR1 (transforming growth factor beta receptor 1) [NCBI Gene 7046] {aka AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, NEFM (neurofilament medium chain) [NCBI Gene 4741] {aka NEF3, NF-M, NFM}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, SMAD2 (SMAD family member 2) [NCBI Gene 4087] {aka CHTD8, JV18, JV18-1, LDS6, MADH2, MADR2}, FSD2 (fibronectin type III and SPRY domain containing 2) [NCBI Gene 123722] {aka SPRYD1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}
- **Diseases:** NCC (MESH:D020019), neglected tropical disease (MESH:D058069), foodborne infections (MESH:D005517), inflammation (MESH:D007249), T. solium infection (MESH:D013622), Cysticercosis (MESH:D003551), parasitic infection (MESH:D010272), infectious diseases (MESH:D003141), deaths (MESH:D003643), leukemia (MESH:D007938), Infections (MESH:D007239), immune (MESH:D007154)
- **Chemicals:** TRIzol (MESH:C411644), SDS (MESH:D012967), Cy5.5 (MESH:C098793), Ni (MESH:D009532), PMA (MESH:D013755), peridinin (MESH:C016040), chlorophyll (MESH:D002734), streptomycin (MESH:D013307), CO2 (MESH:D002245), PBS (MESH:D007854), Buffered Saline with Tween (-), penicillin (MESH:D010406), ionomycin (MESH:D015759)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Mus musculus (house mouse, species) [taxon 10090], Taenia solium (pig tapeworm, species) [taxon 6204], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** Clone E6-1 — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0367), Jurkat — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065), 293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920504/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12920504/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920504/full.md

---
Source: https://tomesphere.com/paper/PMC12920504